NVO 241220 103.00C (NVO241220C103000) Stock Options, News & Quotes

0.01
-3.49-99.71%

15min DelayClose Dec 20 16:00 ET

0.01High0.01Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

AusMario838

16 hours ago

$Novo-Nordisk A/S (NVO.US)$ Waoooo so cheapp now

Ultratech

Yesterday 02:14

$Novo-Nordisk A/S (NVO.US)$
no idea whats up w/ nvo for entry but nvox is a new leaveraged ticker. it just started recently so hadn't had a chance to go up yet before tanking. this is the complete history of ticker.
$Defiance Daily Target 2X Long NVO ETF (NVOX.US)$

Money Thrill : Good drop is an Good buy now. Analysts do not know anything about this company and others medicines? Also about statistics... never believe them ? Shall explain later, first buy

Report
Reply

Cancel Reply
Ultratech OP Money Thrill : well i don't know anything about them either so idk if it's a good buy now or if should wait

Report
Reply

Cancel Reply
Money Thrill : I suppose it is now the moment, the next days to follow and buy. I have many articles of it, investments, new drugs etc ... And about the statistics? Here better information.
A pipeline, one that built on the previous blockbusters. But the latest research results were disappointing. A test with some 3,400 patients led to an average weight loss of 22.7% after 68 weeks, which was less than the 25% the company had expected. It scored "only as well" as Zepbound from competitor Eli Lilly, which is already on the market.
Nevertheless, Novo Nordisk will ask the regulators of the pharmaceutical industry to allow the drug to be commercialized. In doing so, they also point to a number of research limitations. Fewer than six out of ten obese patients are said to have used the highest permitted dose.
Investors reacted negatively and immediately pressed the sell button. Yesterday, the share fell almost 21% to 589.20 Danish krone (79 euros). In trading, it had briefly lost almost 30%.

Report
Reply

Cancel Reply
Ultratech OP Money Thrill : I'm saying for others who may be looking at the leaveraged etf i posted. medical/bio stuff isn't my thing

Report
Reply

Cancel Reply
Money Thrill : All statistics are subject to interpretation... limitations? So, never 100% reliable !!! But it is better so, if they wants to regulate it in US ? Lesser than Eli Lilly ".... reading between the lines .... "

Report
Reply

Cancel Reply

View more comments...

Phil Dunn

Yesterday 01:00

Review of the very harsh 3rd week Dec

Devastating Crash of $Novo-Nordisk A/S (NVO.US)$ and Strong Rebound of $NVIDIA (NVDA.US)$ on Black Friday.
I made a difficult but crucial decision on Friday to sell off losing positions at pre-market which were moving downtrend so badly like $Novo-Nordisk A/S (NVO.US)$ , $D.R. Horton (DHI.US)$ , $Huntington Ingalls Industries (HII.US)$ , $MarketAxess (MKTX.US)$ . Especially obesity drug giant NVO which collapsed 25% at pre-market after disappointing trial results o...

Powell says no hurry for Fed rate cuts, how will you adjust your investment strategy?

Chad Dunbar

Dec 21 01:25

I feel good about the second half of the week…

I sold out of $Novo-Nordisk A/S (NVO.US)$ early on Thursday and bought into $Micron Technology (MU.US)$ at just below $85, perfectly dodging Friday’s drop on Novo and getting into Micron at fire sale prices.
I’d like to think that it was the result of some 9-dimensional formula with repeatable outputs…but in actuality, it was just financial Ultra Instinct (with even less consistency and internal logic than Goku’s powers)…
I got out of Novo for reasons ...

Trent Stevenson714

Dec 20 17:43

$Novo-Nordisk A/S (NVO.US)$ i bought dip. honedt opinions